Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells

BACKGROUND: Despite new progress of chemotherapy in multiple myeloma (MM) clinical treatment, MM is still a refractory disease and new technology is needed to improve the outcomes and prolong the survival. Cold atmospheric plasma is a rapidly developed technology in recent years, which has been wide...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dehui, Xu, Yujing, Ning, Ning, Cui, Qingjie, Liu, Zhijie, Wang, Xiaohua, Liu, Dingxin, Chen, Hailan, Kong, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859683/
https://www.ncbi.nlm.nih.gov/pubmed/29568236
http://dx.doi.org/10.1186/s12935-018-0541-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859683/
https://www.ncbi.nlm.nih.gov/pubmed/29568236
http://dx.doi.org/10.1186/s12935-018-0541-z

Ejemplares similares